The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan
Abstract
This review outlines the significance of establishing general rules, a nationwide follow-up survey, and clinical practice guidelines for liver cancer in Japan. The general rules are an essential part of hepatocellular carcinoma (HCC) treatment, enabling a ‘common language' to be used in daily clinical practice and for the nationwide follow-up survey. The Japanese General Rules for the Clinical and Pathological Study of Primary Liver Cancer, which provide detailed descriptions of HCC, are excellent and are unique to Japan. Items in the General Rules for the Clinical and Pathological Study of Primary Liver Cancer are used substantially in another important project, the Nationwide Follow-Up Survey of Primary Liver Cancer, which has been rigorously undertaken with great effort by the Liver Cancer Study Group of Japan biannually since 1969. Both evidence-based and consensus-based treatment algorithms for HCC are used to complement each other in clinical practice in Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kudo, M., Izumi, N., Kokudo, N., Matsui, O., Sakamoto, M., Nakashima, O., Kojiro, M., Makuuchi, M., & for the HCC Expert Panel of Japan Society of Hepatology (2011) · Digestive Diseases · doi:10.1159/000327577 · Cited by 825
Self-citationKudo, M., Matsui, O., Izumi, N., Iijima, H., Kadoya, M., Imai, Y., Okusaka, T., Miyayama, S., Tsuchiya, K., Ueshima, K., et al. (2014) · Liver Cancer · doi:10.1159/000343875 · Cited by 615
Self-citationKokudo, N., Hasegawa, K., Akahane, M., Igaki, H., Izumi, N., Ichida, T., Uemoto, S., Kaneko, S., Kawasaki, S., Ku, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12464 · Cited by 391
Self-citationTransarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Kudo, M., Matsui, O., Izumi, N., Kadoya, M., Okusaka, T., Miyayama, S., Yamakado, K., Tsuchiya, K., Ueshima, K., Hiraoka, A., et al. (2014) · Oncology · doi:10.1159/000368142 · Cited by 283
Self-citationSurveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan
Kudo, M. (2015) · Liver Cancer · doi:10.1159/000367727 · Cited by 198
Self-citationToyoda, H., Kumada, T., Tada, T., Sone, Y., Kaneoka, Y., & Maeda, A. (2015) · Liver Cancer · doi:10.1159/000367735 · Cited by 166
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
Raoul, J., Gilabert, M., & Piana, G. (2014) · Liver Cancer · doi:10.1159/000343867 · Cited by 150
Kudo, M., Kubo, S., Takayasu, K., Sakamoto, M., Tanaka, M., Ikai, I., Furuse, J., Nakamura, K. D., & Makuuchi, M. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00674.x · Cited by 145
Self-citationKokudo, N., & Makuuchi, M. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2244-z · Cited by 141
Song, P., Gao, J., Inagaki, Y., Kokudo, N., Hasegawa, K., Sugawara, Y., & Tang, W. (2013) · Liver Cancer · doi:10.1159/000346220 · Cited by 105
A Worldwide Survey of the Current Daily Practice in Liver Surgery
Mise, Y., Sakamoto, Y., Ishizawa, T., Kaneko, J., Aoki, T., Hasegawa, K., Sugawara, Y., & Kokudo, N. (2013) · Liver Cancer · doi:10.1159/000346225 · Cited by 94
Toyoda, H., Kumada, T., Tada, T., Sone, Y., Kaneoka, Y., Maeda, A., Minami, Y., Kudo, M., Siegel, A. B., El-Khoueiry, A. B., et al. (2015) · Liver Cancer · doi:10.1159/000367730 · Cited by 82
Self-citationDrug Therapy for Advanced-Stage Liver Cancer
Peck‐Radosavljevic, M. (2014) · Liver Cancer · doi:10.1159/000343868 · Cited by 79
IHPBA concordant classification of primary liver cancer: working group report
Makuuchi, M., Belghiti, J., Belli, G., Fan, S.-T., Lau, J. W. Y., Ringe, B., Strasberg, S. M., Vauthey, J., Yamaoka, Y., & Yamasaki, S. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s10534-002-0808-6 · Cited by 69
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)
Kudo, M., Ueshima, K., Kubo, S., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12542 · Cited by 61
Self-citationLocoregional Therapy for Hepatocellular Carcinoma
Obi, S., Sato, S., Kawai, T., Ichikawa, S., Ichikawa, T., Motosugi, U., Sano, K., Morisaka, H., Enomoto, N., Matsuda, M., et al. (2015) · Liver Cancer · doi:10.1159/000367741 · Cited by 54
Siegel, A. B., El-Khoueiry, A. B., Finn, R. S., Guthrie, K. A., Goyal, A., Venook, A. P., Blanke, C. D., Verna, E. C., Dove, L. M., Emond, J. C., et al. (2015) · Liver Cancer · doi:10.1159/000367734 · Cited by 30
Cited by
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Self-citationHiraoka, A., Michitaka, K., Kumada, T., Izumi, N., Kadoya, M., Kokudo, N., Kubo, S., Matsuyama, Y., Nakashima, O., Sakamoto, M., et al. (2017) · Liver Cancer · doi:10.1159/000479984 · Cited by 331
Self-citationYoon, J. S., Lee, H. A., Park, J. Y., Kim, B. H., Lee, I. J., Chon, Y. E., Hong, S. K., Lee, D. H., Kong, H.-J., Won, Y.-J., et al. (2020) · Journal of Liver Cancer · doi:10.17998/jlc.20.1.41 · Cited by 19
Gavriilidis, P., Hammond, J. S., & Hidalgo, E. (2020) · HPB · doi:10.1016/j.hpb.2020.07.006 · Cited by 16
Metadata
- Authors
- Kudo, M., Kitano, M., Sakurai, T., & Nishida, N.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 33
- Issue
- 6
- Pages
- 765-770
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2176831251
- Cited by
- 288
- References
- 17
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.